Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Analyse

Nexstim: Toward a year of new openings

Af Antti SiltanenAnalytiker
Nexstim
Download analyse (PDF)

In H2, Nexstim's net sales were well below our estimates while the operating loss was in line with our expectation. We lowered our net sales estimates for the next few years but left our longer-term growth expectations unchanged. Our EBIT estimates rise with a better profitability outlook. The valuation picture is more attractive than before with the outlook and lower share price.

Nexstim

3,96EUR27.02.2023, 18.00
4,30EURKursmål
Reducer
Anbefaling opdateret:22.02.2023

Nexstim operates in medical technology. The company has developed a non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with 3D navigation providing targeting of the TMS to the specific area of the brain. The technology is aimed for the treatment of major depression and chronic neuropathic pain. The company was founded in 2000 and has its headquarters in Helsinki.

Read more on company page

Key Estimate Figures22.02.2023

202122e23e
Omsætning6,410,28,5
vækst-%55,5 %60,1 %-17,0 %
EBIT (adj.)-1,50,9-1,3
EBIT-% (adj.)-22,7 %9,0 %-15,6 %
EPS (adj.)-0,110,24-0,20
Udbytte0,000,000,00
Udbytte %
P/E (adj.)neg.61,8neg.
EV/EBITDAneg.78,4neg.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team